Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

This study is to evaluate the efficacy and safety of SJP002 ophthalmic solution compared to placebo in patients with Dry Eye Syndrome.

Phase 2

Samjin Pharmaceutical Co., Ltd.

Ophthalmic Solutions